Cite
Gurevich A, Schenk J, Wellhoefer H, et al. A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. . Mol Genet Metab Rep. 2019;19:100471doi: 10.1016/j.ymgmr.2019.100471.
Gurevich, A., Schenk, J., Wellhoefer, H., & Kalampoki, V. (2019). A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. . Molecular genetics and metabolism reports, 19100471. https://doi.org/10.1016/j.ymgmr.2019.100471
Gurevich, Andrey, et al. "A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. ." Molecular genetics and metabolism reports vol. 19 (2019): 100471. doi: https://doi.org/10.1016/j.ymgmr.2019.100471
Gurevich A, Schenk J, Wellhoefer H, Kalampoki V. A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. . Mol Genet Metab Rep. 2019 Apr 13;19:100471. doi: 10.1016/j.ymgmr.2019.100471. eCollection 2019 Jun. PMID: 31011537; PMCID: PMC6462757.
Copy
Download .nbib
